| Dr Faisal Wasi, MD | |
|
905 Nw 5th St, Stigler, OK 74462-1611 | |
| (918) 967-0072 | |
| (918) 967-5040 |
| Full Name | Dr Faisal Wasi |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 28 Years |
| Location | 905 Nw 5th St, Stigler, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689672263 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 1123832 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Traditions Home Care, Inc | Mcalester, OK | Home health agency |
| Oklahoma Healthcare Solutions I X | Henryetta, OK | Home health agency |
| Cherokee Nation Home Health Services | Tahlequah, OK | Home health agency |
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| Saint Francis Hospital Muskogee | Muskogee, OK | Hospital |
| Saint Francis Hospital South, Llc | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Faisal Wasi Md, Pc | 1557493228 | 4 |
News Archive
SMU Office of Research and Tech Transfer - In response to the rapidly evolving COVID-19 pandemic, the Psychological Science Accelerator issued a call on March 13th for rapid and impactful proposals to understand the psychological and behavioural aspects of the pandemic.
A team of engineers at the Harvard School of Engineering and Applied Sciences (SEAS), Schlumberger-Doll Research Center in Cambridge, Mass., and the University of Texas, Austin, have created a truly portable device for nuclear magnetic resonance (NMR) spectroscopy.
The coalition, which is made up of health care providers, unions, businesses, religious organizations and others, views this effort as its back up plan if state legislators block Gov. John Kasich's push to expand the low income health insurance program.
Children who spend more time in less structured activities-from playing outside to reading books to visiting the zoo-are better able to set their own goals and take actions to meet those goals without prodding from adults, according to a new study by the University of Colorado Boulder.
Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, today reported positive data from the completed Phase 1 multiple ascending dose, placebo controlled clinical trial of BNC210, an orally administered negative allosteric modulator of the alpha-7 nicotinic acetylcholine receptor (alpha-7 receptor) being developed for the treatment of anxiety and depression.
› Verified 8 days ago
| Entity Name | Faisal Wasi Md, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265757827 PECOS PAC ID: 1557493228 Enrollment ID: O20100715000330 |
News Archive
SMU Office of Research and Tech Transfer - In response to the rapidly evolving COVID-19 pandemic, the Psychological Science Accelerator issued a call on March 13th for rapid and impactful proposals to understand the psychological and behavioural aspects of the pandemic.
A team of engineers at the Harvard School of Engineering and Applied Sciences (SEAS), Schlumberger-Doll Research Center in Cambridge, Mass., and the University of Texas, Austin, have created a truly portable device for nuclear magnetic resonance (NMR) spectroscopy.
The coalition, which is made up of health care providers, unions, businesses, religious organizations and others, views this effort as its back up plan if state legislators block Gov. John Kasich's push to expand the low income health insurance program.
Children who spend more time in less structured activities-from playing outside to reading books to visiting the zoo-are better able to set their own goals and take actions to meet those goals without prodding from adults, according to a new study by the University of Colorado Boulder.
Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, today reported positive data from the completed Phase 1 multiple ascending dose, placebo controlled clinical trial of BNC210, an orally administered negative allosteric modulator of the alpha-7 nicotinic acetylcholine receptor (alpha-7 receptor) being developed for the treatment of anxiety and depression.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Faisal Wasi, MD 905 Nw 5th St, Stigler, OK 74462-1611 Ph: (918) 967-0072 | Dr Faisal Wasi, MD 905 Nw 5th St, Stigler, OK 74462-1611 Ph: (918) 967-0072 |
News Archive
SMU Office of Research and Tech Transfer - In response to the rapidly evolving COVID-19 pandemic, the Psychological Science Accelerator issued a call on March 13th for rapid and impactful proposals to understand the psychological and behavioural aspects of the pandemic.
A team of engineers at the Harvard School of Engineering and Applied Sciences (SEAS), Schlumberger-Doll Research Center in Cambridge, Mass., and the University of Texas, Austin, have created a truly portable device for nuclear magnetic resonance (NMR) spectroscopy.
The coalition, which is made up of health care providers, unions, businesses, religious organizations and others, views this effort as its back up plan if state legislators block Gov. John Kasich's push to expand the low income health insurance program.
Children who spend more time in less structured activities-from playing outside to reading books to visiting the zoo-are better able to set their own goals and take actions to meet those goals without prodding from adults, according to a new study by the University of Colorado Boulder.
Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, today reported positive data from the completed Phase 1 multiple ascending dose, placebo controlled clinical trial of BNC210, an orally administered negative allosteric modulator of the alpha-7 nicotinic acetylcholine receptor (alpha-7 receptor) being developed for the treatment of anxiety and depression.
› Verified 8 days ago